Free Trial

Chemed (CHE) Stock Price, News & Analysis

Chemed logo
$460.18 +0.56 (+0.12%)
Closing price 03:59 PM Eastern
Extended Trading
$459.62 -0.56 (-0.12%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chemed Stock (NYSE:CHE)

Key Stats

Today's Range
$455.81
$462.88
50-Day Range
$412.98
$558.68
52-Week Range
$408.42
$623.60
Volume
166,583 shs
Average Volume
140,537 shs
Market Capitalization
$6.70 billion
P/E Ratio
23.66
Dividend Yield
0.52%
Price Target
$592.25
Consensus Rating
Buy

Company Overview

Chemed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

CHE MarketRank™: 

Chemed scored higher than 100% of companies evaluated by MarketBeat, and ranked 9th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Chemed has only been the subject of 4 research reports in the past 90 days.

  • Read more about Chemed's stock forecast and price target.
  • Earnings Growth

    Earnings for Chemed are expected to grow by 8.73% in the coming year, from $21.43 to $23.30 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemed is 23.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 271.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemed is 23.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.01.

  • Price to Earnings Growth Ratio

    Chemed has a PEG Ratio of 2.52. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Chemed has a P/B Ratio of 5.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemed's valuation and earnings.
  • Percentage of Shares Shorted

    3.59% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 33.45%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Chemed has a dividend yield of 0.52%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemed has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Chemed is 12.34%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chemed will have a dividend payout ratio of 10.30% next year. This indicates that Chemed will be able to sustain or increase its dividend.

  • Read more about Chemed's dividend.
  • Percentage of Shares Shorted

    3.59% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 33.45%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Chemed has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Chemed this week, compared to 11 articles on an average week.
  • Search Interest

    Only 2 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Chemed to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemed insiders have sold 4,963.73% more of their company's stock than they have bought. Specifically, they have bought $83,420.00 in company stock and sold $4,224,163.00 in company stock.

  • Percentage Held by Insiders

    Only 3.29% of the stock of Chemed is held by insiders.

  • Percentage Held by Institutions

    95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemed's insider trading history.
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHE Stock News Headlines

Chemed (NYSE:CHE) Upgraded at Jefferies Financial Group
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Chemed management to meet with Oppenheimer
Forecasting The Future: 6 Analyst Projections For Chemed
Why Chemed (CHE) Stock Is Up Today
See More Headlines

CHE Stock Analysis - Frequently Asked Questions

Chemed's stock was trading at $529.80 at the beginning of 2025. Since then, CHE shares have decreased by 13.1% and is now trading at $460.1850.

Chemed Corporation (NYSE:CHE) released its quarterly earnings results on Tuesday, July, 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by $1.75. The firm's quarterly revenue was up 3.8% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional investors of Chemed include State Street Corp (3.27%), Geode Capital Management LLC (2.44%), William Blair Investment Management LLC (2.32%) and Impax Asset Management Group plc (1.84%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Andrea R Lindell, George J Walsh III, Patrick P Grace, Michael D Witzeman, Brian C Judkins and Nicholas Michael Westfall.
View institutional ownership trends
.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Record date for 6/17 Dividend
5/29/2025
Ex-Dividend for 6/17 Dividend
5/29/2025
Dividend Payable
6/17/2025
Last Earnings
7/29/2025
Record date for 8/29 Dividend
8/11/2025
Ex-Dividend for 8/29 Dividend
8/11/2025
Dividend Payable
8/29/2025
Today
9/04/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NYSE:CHE
CIK
19584
Employees
15,695
Year Founded
1970

Price Target and Rating

High Price Target
$650.00
Low Price Target
$550.00
Potential Upside/Downside
+28.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$19.45
Trailing P/E Ratio
23.66
Forward P/E Ratio
21.47
P/E Growth
2.52
Net Income
$302 million
Net Margins
11.56%
Pretax Margin
15.44%
Return on Equity
25.83%
Return on Assets
17.77%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.86
Quick Ratio
1.83

Sales & Book Value

Annual Sales
$2.43 billion
Price / Sales
2.76
Cash Flow
$25.84 per share
Price / Cash Flow
17.81
Book Value
$82.25 per share
Price / Book
5.59

Miscellaneous

Outstanding Shares
14,570,000
Free Float
14,093,000
Market Cap
$6.70 billion
Optionable
Optionable
Beta
0.46

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:CHE) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners